Chugai Group
|
Contact Us
|
Sitemap
About
Company Profile
Our Mission, Vision and Values
Meet Our CEO
Meet Our Chairman
Meet Our Directors
Our History
Chugai Japan
Science and Technology
Antibody Engineering Technology
Cyclic Peptide Technology
AAALAC Accreditation
People
Research Division
Admin Division
LabStories
Careers
Job Openings
FAQs
Sustainability
Initiative For Society
News Room
News Release
Company Events
Science Events
Media
Company Brochure
Publications
Meeting Conferences
Collaboration
Search for:
Search for:
Contact
About
Company Profile
Our Mission, Vision and Values
Meet Our CEO
Meet Our Chairman
Meet Our Directors
Our History
Chugai Japan
Science and Technology
Antibody Engineering Technology
Cyclic Peptide Technology
AAALAC Accreditation
People
Research Division
Admin Division
LabStories
Careers
Job Openings
FAQs
Sustainability
Initiative For Society
News Room
News Release
Company Events
Science Events
Media
Company Brochure
Publications
Meeting Conferences
Collaboration
About
Find out more
About
Find out more
Sustainability
Find out more
Sustainability
Find out more
News Releases
Notice of Absorption-Type Merger of a Wholly-Owned Subsidiary, Renalys Pharma, Inc.
Source: Chugai Pharmaceutical: News Releases
November 18, 2025
Roche Announces Global Phase III INShore Study Topline Results on Gazyva for Idiopathic Nephrotic Syndrome in Children and Young Adults
Source: Chugai Pharmaceutical: News Releases
October 30, 2025
Chugai Announces 2025 3rd Quarter Results
Source: Chugai Pharmaceutical: News Releases
October 24, 2025
More news
Science and Technology
Find out more
Science and Technology
Find out more
Careers at Chugai
Join us
Careers at Chugai
Join us
Videos
CPR celebrates 10th Anniversary
More videos
Automated page speed optimizations for fast site performance